TRCT
IMA

Tower Research Capital (TRC)’s ImageneBio Inc IMA Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98K Sell
675
-336
-33% -$1.9K ﹤0.01% 4443
2026
Q1 		$5.05K Buy
+1,011
New +$6.56K ﹤0.01% 4145
2025
Q4 		– Sell
-877
Closed -$7.15K – 5362
2025
Q3 		$7.15K Buy
877
+687
+362% +$9.11K ﹤0.01% 4114
2025
Q2 		$3.05K Buy
+190
New +$2.79K ﹤0.01% 4560
2025
Q1 		– Sell
-303
Closed -$5.96K – 5480
2024
Q4 		$5.96K Buy
303
+147
+94% +$2.97K ﹤0.01% 4219
2024
Q3 		$3.24K Sell
156
-1,522
-91% -$30.8K ﹤0.01% 4877
2024
Q2 		$33.2K Buy
1,678
+934
+126% +$16.5K ﹤0.01% 3409
2024
Q1 		$12.7K Buy
744
+328
+79% +$5.97K ﹤0.01% 3457
2023
Q4 		$9.84K Buy
416
+107
+35% +$3.49K ﹤0.01% 4339
2023
Q3 		$16.1K Buy
309
+233
+307% +$14K ﹤0.01% 3574
2023
Q2 		$6.01K Sell
76
-221
-74% -$15.8K ﹤0.01% 4752
2023
Q1 		$13K Sell
297
-863
-74% -$39.7K ﹤0.01% 3975
2022
Q4 		$37K Buy
1,160
+840
+263% +$26.8K ﹤0.01% 2565
2022
Q3 		$13K Buy
320
+56
+21% +$3.24K ﹤0.01% 4271
2022
Q2 		$14K Buy
264
+114
+76% +$6.29K ﹤0.01% 4141
2022
Q1 		$11K Buy
150
+4
+3% +$425 ﹤0.01% 4177
2021
Q4 		$22K Buy
146
+84
+135% +$13.6K ﹤0.01% 3563
2021
Q3 		$9K Sell
62
-40
-39% -$5.81K ﹤0.01% 4441
2021
Q2 		$17K Buy
+102
New +$22.5K ﹤0.01% 4043

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Tower Research Capital (TRC)'s IMA Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its ImageneBio Inc (IMA) stake by 33% in Q2 2026, selling an estimated $1.9K and leaving 675 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Tower Research Capital (TRC) first reported a position in IMA in Q2 2021 and has held it in 19 quarters since. The position peaked at $37K in Q4 2022. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Tower Research Capital (TRC) held 675 shares of ImageneBio Inc worth $3.98K as of Q2 2026.
  • Tower Research Capital (TRC) sold 336 ImageneBio Inc shares in Q2 2026, an estimated $1.9K.
  • ImageneBio Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4443 holding.
  • Tower Research Capital (TRC) first reported a position in ImageneBio Inc in Q2 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s ImageneBio Inc position peaked at $37K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.